Characterization of the cloned full-length and a truncated human target of rapamycin: Activity, specificity, and enzyme inhibition as studied by a high capacity assay
- 24 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 332 (1) , 304-310
- https://doi.org/10.1016/j.bbrc.2005.04.117
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dysregulation of the TSC-mTOR pathway in human diseaseNature Genetics, 2004
- The tor pathway: a target for cancer therapyNature Reviews Cancer, 2004
- Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progressionOncogene, 2004
- TOR, a Central Controller of Cell GrowthCell, 2000
- The FKBP12-Rapamycin-binding Domain Is Required for FKBP12-Rapamycin-associated Protein Kinase Activity and G1 ProgressionJournal of Biological Chemistry, 1999
- RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1Proceedings of the National Academy of Sciences, 1998
- Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of RapamycinScience, 1997
- Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAPScience, 1996
- PIK-Related Kinases: DNA Repair, Recombination, and Cell Cycle CheckpointsScience, 1995
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994